The global Intra-abdominal Infection Treatment Drugs Market is experiencing steady expansion, driven by rising incidences of intra-abdominal infections (IAIs), advancements in antimicrobial therapies, and increasing healthcare awareness. According to The Insight Partners, the market is projected to grow from US$ 10.81 Billion in 2025 to US$ 16.99 Billion by 2034,...